0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Attenuated Measles Vaccine in Children with Acute Leukemia

ANNA MITUS, M.R.C.S., ENG.; ANN HOLLOWAY, B.S.; AUDREY E. EVANS, L.R.C.P., S.E.; JOHN F. ENDERS, Ph.D.
Am J Dis Child. 1962;103(3):413-418. doi:10.1001/archpedi.1962.02080020425051.
Text Size: A A A
Published online

It has been shown by Mitus and her associates1-3 that infection with measles virus in children with acute leukemia may occasionally terminate fatally. At autopsy in such cases, pathological changes characteristic of giant-cell pneumonia are present. The etiologic agent in all cases of this condition examined thus far has proved to be measles virus. These workers also found that prophylactic administration of γ-globulin cannot be relied upon to prevent the development of measles giant-cell pneumonia.

Accordingly, the possibility of protecting this unusually vulnerable sort of patient by means of vaccination with attenuated measles virus vaccine was considered. The decision to vaccinate a small selected group of children was taken only after carefully weighing the possible untoward effects of the vaccine against the grave risk attendant upon infection naturally acquired.

In the first part of this communication, abnormal as well as normal reactions to measles of different children with acute

Topics

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();